| Name | Title | Contact Details |
|---|---|---|
Joshua Grey |
Senior Counsel | Profile |
Diane Marciano |
Vice President Business Development Government Affairs | Profile |
Adam French |
Senior Director and Associate Counsel | Profile |
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.
Aid in Recovery is a addiction treatment center referral service.
Goode Consulting Intl is a Pompano Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Lively provides hearing devices from the convenience of your home, all under the guidance of a doctor for 50% less than the national average.
BL Software Systems/BL Healthcare is a Foxborough, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.